Idaho Veterans Research & Education

“Va directors are ex-officio per the organization's by-laws. Other directors and officers are elected by a majority vote of the board of directors.”

“Articles and by-laws dictate that certain actions may be taken by a majority vote of the va directors.”

“A copy of the form 990 is available to all directors prior to filing of the return. The executive director and chief finance officer reviews the form 990 before signing and reports any items of concern to the other directors.”

“The board of directors are responsible for determining, reviewing, and approving the executive director's compensation.”

“The organization makes its governing documents and financial statements available to the public upon reasonable written request for such information.”

“Expenditures related to research and education. Research expenses associated with the following major grant projects: 1)nih (u of idaho sub-award) - idaho inbre program ivref doucette 2)nih (u of idaho sub-award) - dhhs nih inbre4 ivref hobdey drp 3)nih r21 - role of mir-181a-5p in adenovirus 14p1 induced acute lung injury 4)nih ro3 - development of antibodies to specific cell surface markers to assess macrophage polarization during adenovirus 14 and 14p1 infection in the syrian hamster. 5) nih (u of pittsburgh sub-award) - macs/wihs ccs kunisaki 6)pcori (sibcr sub-award) - functional improvement in osa and copd with a telehealth lifestyle and exercise intervention (focused) 7)paratek pharmaceuticals - investigating the anti-inflammatory activities of omadacycline 8)alto pharmaceuticals - a randomized, double-blind, placebo-controlled study of alto-300 with an open-label extension in adults with major depressive disorder. 9)janssen research & development - multicohort study to customize ibrutinib treatment regimens for patients with previously untreated chronic lymphocytic leukemia 10)ferring pharmaceuticals - a phase 2, randomized, multi-center, open- label trial to evaluate the safety and efficacy of intravesical nadofaragene firadenovec alone or in combination with chemotherapy (gemcitabine and docetaxel) or immunotherapy (pembrolizumab) in subjects with high-grade bacillus calmette-guerin (bcg) unresponsive non-muscle invasive bladder cancer (nmibc) 11)stability biologics - a multicenter, prospective, randomized controlled modified multi-platform (matriarch) trial evaluating several cellular, acellular, and matrix-like products (camps) and standard of care versus standard of care alone in the management of nonhealing diabetic foot and venous leg ulcers”

“Rounding 4 beginning net assets as of september 30, 2024 have been reclassified by 48,7844 from net assets with donor restrictions to net assets without donor restrictions. This reclassification affects presentation only and does not change total net assets.”